Radioiodinated ligands for the estrogen receptor: effect of different 7-cyanoalkyl chains on the binding affinity of novel iodovinyl-6-dehydroestradiols.

[1]  A. Almeida,et al.  Synthesis and biodistribution studies of two novel radioiodinated areno‐annelated estra‐1,3,5(10),16‐tetraene‐3‐ols as promising estrogen receptor radioligands , 2006 .

[2]  B. Zhu,et al.  Synthesis of 7α-substituted derivatives of 17β-estradiol , 2006, Steroids.

[3]  T. Thiemann,et al.  Synthesis of C7-Substituted Estra-1,3,5(10),6-Tetraen-3,17 β-Diols , 2006 .

[4]  D. Moras,et al.  Binding of Estrogenic Compounds to Recombinant Estrogen Receptor-α: Application to Environmental Analysis , 2004, Environmental health perspectives.

[5]  T. Thiemann,et al.  Synthesis and biological evaluation of two new radiolabelled estrogens: [125I](E)-3-methoxy-17α-iodovinylestra-1,3,5(10),6-tetraen-17β-ol and [125I](Z)-3-methoxy-17α-iodovinylestra-1,3,5(10),6-tetraen-17β-ol , 2001 .

[6]  E. Desombre,et al.  Cytotoxicity of 125 I-oestrogen decay in non-oestrogen receptor-expressing human breast cancer cells, MDA-231 and oestrogen receptor-expressing MCF-7 cells , 2001 .

[7]  G. Slegers,et al.  Radiolabeled estradiol derivatives to predict response to hormonal treatment in breast cancer: a review , 2000, European Journal of Nuclear Medicine.

[8]  T. Kearney,et al.  Therapy of Estrogen Receptor-Positive Micrometastases in the Peritoneal Cavity with Auger Electron-Emitting Estrogens - Theoretical and Practical Considerations , 2000, Acta oncologica.

[9]  K. Hofer.  Biophysical Aspects of Auger Processes , 2000, Acta oncologica.

[10]  M. Ercan,et al.  Therapeutic radiopharmaceuticals. , 2000, Current pharmaceutical design.

[11]  R. Favoni,et al.  Estrogens, progestins and their antagonists vols 1 and 2 , 1997 .

[12]  John A. Katzenellenbogen,et al.  The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site , 1997, Steroids.

[13]  I. Szumiel.  Ionizing radiation-induced cell death. , 1994, International journal of radiation biology.

[14]  C. H. Cummins.  Radiolabeled steroidal estrogens in cancer research , 1993, Steroids.

[15]  J. Rousseau,et al.  Synthesis, receptor binding, and tissue distribution of 7 alpha- and 11 beta-substituted (17 alpha,20E)- and (17 alpha,20Z)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17-diols. , 1991, Journal of medicinal chemistry.

[16]  T. Wheldon,et al.  The radiobiology of targeted radiotherapy. , 1990, International journal of radiation biology.

[17]  W. Bloomer,et al.  Cytotoxicity of Receptor-Mediated 16α[125I]Iodo-estradiol in Cultured MCF-7 Human Breast Cancer Cells , 1989 .

[18]  J. Rousseau,et al.  Synthesis, receptor binding, and tissue distribution of (17 alpha,20E)- and (17 alpha,20Z)-21-[125I]iodo-19-norpregna-1,3,5(10), 20-tetraene-3,17-diol . , 1988, Journal of medicinal chemistry.

[19]  H. Hofmeister,et al.  Synthesis of 17α-bromovinyl- and 17α-iodovinylnortestosterone derivatives , 1986 .